课题基金 / 基金详情

Anti Tac Antibody Treatment in Behcet's Disease

Anti Tac Antibody Treatment in Behcet's Disease
白塞氏病的抗 Tac 抗体治疗
批准号:
6227961
负责人:
ROBERT B. NUSSENBLATT
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

ROBERT B. NUSSENBLATT的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a randomized masked pilot trial of Zenapax (a humanized anti- Tac antibody) vs placebo combined with standard therapy in the treatment of the ocular complications of Behcets disease. The primary goal of the study is to investigate the safety and efficacy of Zenapax in controlling the recurrent explosive nature of ocular manifestations in patients with Behcets disease. Twenty patients will be randomly assigned. The primary efficacy outcomes of the study are based on the number of ocular attacks experienced and the amount of immunosuppressive medications over the 2 year study period. Secondary efficacy outcomes include the level of inflammation. - Behcet's disease, anti-Tac antibody, uveitis, retinal vasculitis - Human Subjects
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biology/Immunology Of Corneal Epithelial Stem Cells
  • 批准号:
    6507406
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROBERT B. NUSSENBLATT
  • 依托单位:
Nucleotide Polymorphisms In Primary Intraocular Lymphoma
  • 批准号:
    6507404
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROBERT B. NUSSENBLATT
  • 依托单位:
Vegf (in Situ Macular Edema & Uveitis
  • 批准号:
    6507390
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROBERT B. NUSSENBLATT
  • 依托单位:
The Use Of An Anti-il2 Receptor Antibody In The Treatmen
  • 批准号:
    6507392
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    ROBERT B. NUSSENBLATT
  • 依托单位: